Scancell Holdings (GB:SCLP) has released an update.
Scancell Holdings Plc, a developer of innovative cancer immunotherapies, has announced its participation in several prominent upcoming conferences to showcase its recent advancements. These events include the BIO International Convention in San Diego and the Antibody Engineering & Therapeutics Europe conference in London, where team members will present and discuss the company’s cutting-edge AvidiMAb® technology. Interested parties are invited to arrange meetings with Scancell’s management through their provided contact details.
For further insights into GB:SCLP stock, check out TipRanks’ Stock Analysis page.
